medigraphic.com
ISSN 2520-9078 (Electronic)

2021, Number 3

Next >>

Revista de Ciencias Médicas de la Habana 2021; 28 (3)

Mycoses as a coinfection in COVID-19

Mendieta PMD

Language: Spanish
References: 10
Page: 308-311
PDF size: 392.25 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson DW, the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA [Internet]. 2020 [citado 31 Jul 2021];323(20):2052-59. Disponible en: https://jamanetwork. com/journals/jama/fullarticle/2765184/

  2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020 [citado 31 Jul 2021];395(10223):497-506. Disponible en: https://www. thelancet. com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext#%20

  3. García Clemente M, Madrid Carbajal C, Iscar Urrutia M. Influenza, SARS-CoV-2 y aspergilosis pulmonar invasiva. Arch Bronconeumol[Internet]. 2021 Jan[citado 31 Jul 2021];57 (S1):11–12. Disponible en: https://www. ncbi. nlm. nih. gov/pmc/articles/PMC7521215/pdf/main. pdf

  4. Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020;323(16):1545-46. doi: https://doi. org/10. 1001/jama. 2020. 4031

  5. Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, et al. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clinical Infectious Diseases. 2020;20: ciaa1065, https://doi. org/10. 1093/cid/ciaa1065

  6. Koehler P, Cornely OA, Böttiger BW, Fabian D, Eichenauer EA, Fuchs F, et al. COVID-19 associated pulmonary aspergillosis. Mycoses[Internet]. 2020 [citado 31 Jul 2021];63(6):528-34. Disponible en: https://onlinelibrary. wiley. com/doi/full/10. 1111/myc. 13096

  7. Alanio A, Delličre S, Fodil S, Bretagne S, Mégarbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020 Jun;8(6):e48-e49. PMID: 32445626 PMCID: PMC7239617

  8. Rutsaert L, Steinfort N, Van Hunsel T, Bomans P, Naesens R, Mertes H, et al. COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care. 2020 Jun;10(1):71. doi: https://doi. org/10. 1186/s13613-020-00686-4

  9. Lamoth F, Glampedakis E, Boillat-Blanco N, Oddo M, Pagani J-L. Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients. Clin Microbiol Infect[Internet]. 2020 Dic[citado 31 Jul 2021];26(12):1706-08. Disponible en: https://www. ncbi. nlm. nih. gov/pmc/articles/PMC7348600/pdf/main. pdf

  10. Segrelles‐Calvo G, Araújo GRS, Llopis‐Pastor E, Carrillo J, Hernández-Hernández M, Rey L, et al. Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia. Mycoses. 2021 Feb;64(2):144-51. doi: https://doi. org/10. 1111/myc. 13219




2020     |     www.medigraphic.com